Related Experiment Video
Updated: Aug 21, 2026

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
Therapy for ventilator-associated pneumonia: what works, what doesn't
Mohammed Hijazi1, Mariam Al-Ansari
1Section of Critical Care Medicine, Department of Medicine, (MBC-46), King Faisal Specialist Hospital and Research Centre, P.O. Box 3354, Riyadh 11211, Saudi Arabia. hijazim@hotmail.com
Abstract:
Ventilator-associated pneumonia is a common cause of morbidity and mortality in critically ill patients. Inappropriate initial antimicrobial therapy is associated with poor outcome. An initial aggressive strategy using broad-spectrum antibiotics based on the local distribution of pathogens, patient risk factors, and antimicrobial characteristics; followed by focused therapy based on microbiologic studies, will help minimize the chance of inappropriate therapy and the emergence of resistance.
Insights
Ventilator-associated pneumonia (VAP) treatment requires an aggressive initial broad-spectrum antibiotic approach. Tailoring therapy based on local pathogens and patient factors improves outcomes and reduces antimicrobial resistance.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pharmacology
Background:
- Ventilator-associated pneumonia (VAP) is a significant contributor to severe illness and death in intensive care units.
- Suboptimal initial antibiotic selection is linked to adverse patient outcomes.
- The emergence of antimicrobial resistance is a growing concern in managing VAP.
Purpose of the Study:
- To outline an evidence-based strategy for optimizing initial antimicrobial therapy in VAP.
- To emphasize the importance of tailoring antibiotic selection to local epidemiology and patient-specific risk factors.
- To reduce the incidence of inappropriate therapy and mitigate the development of antibiotic resistance.
Main Methods:
- Review of current guidelines and literature on VAP management.
- Analysis of factors influencing antimicrobial choice, including pathogen prevalence and resistance patterns.
- Integration of patient risk stratification and pharmacokinetic/pharmacodynamic principles.
Main Results:
- An aggressive, broad-spectrum initial antibiotic regimen is recommended for VAP.
- Therapy should be guided by local antimicrobial susceptibility data and patient risk factors.
- De-escalation of therapy based on subsequent microbiological data is crucial.
Conclusions:
- An initial aggressive, yet informed, antibiotic strategy is vital for improving VAP outcomes.
- Personalized antimicrobial selection, considering local resistance and patient factors, is key.
- Judicious use of antibiotics is essential to combat antimicrobial resistance in critically ill patients.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation I: Indication and Settings
